Intradermal air pouch leukocytosis as an in vivo test for nanoparticles
Jennifer Vandooren,1 Nele Berghmans,1 Chris Dillen,1 Ilse Van Aelst,1 Isabelle Ronsse,1 Liron Limor Israel,2 Ina Rosenberger,3 Jörg Kreuter,3 Jean-Paul Lellouche,2 Shulamit Michaeli,4 Erica Locatelli,5 Mauro Comes Franchini,5 Miren K Aiertza,6 Laura Sánchez-Abella,6 Iraida Loina...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/910c25427a3945dab618e02793f369e7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:910c25427a3945dab618e02793f369e7 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:910c25427a3945dab618e02793f369e72021-12-02T02:31:47ZIntradermal air pouch leukocytosis as an in vivo test for nanoparticles1178-2013https://doaj.org/article/910c25427a3945dab618e02793f369e72013-12-01T00:00:00Zhttp://www.dovepress.com/intradermal-air-pouch-leukocytosis-as-an-in-vivo-test-for-nanoparticle-a15282https://doaj.org/toc/1178-2013 Jennifer Vandooren,1 Nele Berghmans,1 Chris Dillen,1 Ilse Van Aelst,1 Isabelle Ronsse,1 Liron Limor Israel,2 Ina Rosenberger,3 Jörg Kreuter,3 Jean-Paul Lellouche,2 Shulamit Michaeli,4 Erica Locatelli,5 Mauro Comes Franchini,5 Miren K Aiertza,6 Laura Sánchez-Abella,6 Iraida Loinaz,6 Dylan R Edwards,7 Louis Shenkman,8 Ghislain Opdenakker1 1Rega Institute for Medical Research, University of Leuven, Leuven, Belgium; 2Department of Chemistry and Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Tel Aviv, Israel; 3Institut für Pharmazeutische Technologie, Johann Wolfgang Goethe-Universität, Frankfurt, Germany; 4The Mina and Everard Goodman Faculty of Life Sciences and Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat Gan, Tel Aviv, Israel; 5Department of Industrial Chemistry Toso Montanari, University of Bologna, Bologna, Italy; 6New Materials Department, Fundación CIDETEC, San Sebastián, Spain; 7School of Biological Sciences, University of East Anglia, Norwich, UK; 8Tel Aviv University, Ramat Aviv, Tel Aviv, Israel Abstract: The need for test systems for nanoparticle biocompatibility, toxicity, and inflammatory or adaptive immunological responses is paramount. Nanoparticles should be free of microbiological and chemical contaminants, and devoid of toxicity. Nevertheless, in the absence of contamination, these particles may still induce undesired immunological effects in vivo, such as enhanced autoimmunity, hypersensitivity reactions, and fibrosis. Here we show that artificial particles of specific sizes affect immune cell recruitment as tested in a dermal air pouch model in mice. In addition, we demonstrate that the composition of nanoparticles may influence immune cell recruitment in vivo. Aside from biophysical characterizations in terms of hydrodynamic diameter, zeta potential, concentration, and atomic concentration of metals, we show that – after first-line in vitro assays – characterization of cellular and molecular effects by dermal air pouch analysis is straightforward and should be included in the quality control of nanoparticles. We demonstrate this for innate immunological effects such as neutrophil recruitment and the production of immune-modulating matrix metalloproteases such as MMP-9; we propose the use of air pouch leukocytosis analysis as a future standard assay. Keywords: nanoparticles, biocompatibility, toxicity, air pouch, immunologyA Letter to the Editor has been received and published for this article.Vandooren JBerghmans NDillen CVan Aelst IRonsse IIsrael LLRosenberger IKreuter JLellouche JPMichaeli SLocatelli EComes Franchini MAiertza MKSánchez-Abella LLoinaz IEdwards DRShenkman LOpdenakker GDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2013, Iss Issue 1, Pp 4745-4756 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine (General) R5-920 |
spellingShingle |
Medicine (General) R5-920 Vandooren J Berghmans N Dillen C Van Aelst I Ronsse I Israel LL Rosenberger I Kreuter J Lellouche JP Michaeli S Locatelli E Comes Franchini M Aiertza MK Sánchez-Abella L Loinaz I Edwards DR Shenkman L Opdenakker G Intradermal air pouch leukocytosis as an in vivo test for nanoparticles |
description |
Jennifer Vandooren,1 Nele Berghmans,1 Chris Dillen,1 Ilse Van Aelst,1 Isabelle Ronsse,1 Liron Limor Israel,2 Ina Rosenberger,3 Jörg Kreuter,3 Jean-Paul Lellouche,2 Shulamit Michaeli,4 Erica Locatelli,5 Mauro Comes Franchini,5 Miren K Aiertza,6 Laura Sánchez-Abella,6 Iraida Loinaz,6 Dylan R Edwards,7 Louis Shenkman,8 Ghislain Opdenakker1 1Rega Institute for Medical Research, University of Leuven, Leuven, Belgium; 2Department of Chemistry and Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Tel Aviv, Israel; 3Institut für Pharmazeutische Technologie, Johann Wolfgang Goethe-Universität, Frankfurt, Germany; 4The Mina and Everard Goodman Faculty of Life Sciences and Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat Gan, Tel Aviv, Israel; 5Department of Industrial Chemistry Toso Montanari, University of Bologna, Bologna, Italy; 6New Materials Department, Fundación CIDETEC, San Sebastián, Spain; 7School of Biological Sciences, University of East Anglia, Norwich, UK; 8Tel Aviv University, Ramat Aviv, Tel Aviv, Israel Abstract: The need for test systems for nanoparticle biocompatibility, toxicity, and inflammatory or adaptive immunological responses is paramount. Nanoparticles should be free of microbiological and chemical contaminants, and devoid of toxicity. Nevertheless, in the absence of contamination, these particles may still induce undesired immunological effects in vivo, such as enhanced autoimmunity, hypersensitivity reactions, and fibrosis. Here we show that artificial particles of specific sizes affect immune cell recruitment as tested in a dermal air pouch model in mice. In addition, we demonstrate that the composition of nanoparticles may influence immune cell recruitment in vivo. Aside from biophysical characterizations in terms of hydrodynamic diameter, zeta potential, concentration, and atomic concentration of metals, we show that – after first-line in vitro assays – characterization of cellular and molecular effects by dermal air pouch analysis is straightforward and should be included in the quality control of nanoparticles. We demonstrate this for innate immunological effects such as neutrophil recruitment and the production of immune-modulating matrix metalloproteases such as MMP-9; we propose the use of air pouch leukocytosis analysis as a future standard assay. Keywords: nanoparticles, biocompatibility, toxicity, air pouch, immunologyA Letter to the Editor has been received and published for this article. |
format |
article |
author |
Vandooren J Berghmans N Dillen C Van Aelst I Ronsse I Israel LL Rosenberger I Kreuter J Lellouche JP Michaeli S Locatelli E Comes Franchini M Aiertza MK Sánchez-Abella L Loinaz I Edwards DR Shenkman L Opdenakker G |
author_facet |
Vandooren J Berghmans N Dillen C Van Aelst I Ronsse I Israel LL Rosenberger I Kreuter J Lellouche JP Michaeli S Locatelli E Comes Franchini M Aiertza MK Sánchez-Abella L Loinaz I Edwards DR Shenkman L Opdenakker G |
author_sort |
Vandooren J |
title |
Intradermal air pouch leukocytosis as an in vivo test for nanoparticles |
title_short |
Intradermal air pouch leukocytosis as an in vivo test for nanoparticles |
title_full |
Intradermal air pouch leukocytosis as an in vivo test for nanoparticles |
title_fullStr |
Intradermal air pouch leukocytosis as an in vivo test for nanoparticles |
title_full_unstemmed |
Intradermal air pouch leukocytosis as an in vivo test for nanoparticles |
title_sort |
intradermal air pouch leukocytosis as an in vivo test for nanoparticles |
publisher |
Dove Medical Press |
publishDate |
2013 |
url |
https://doaj.org/article/910c25427a3945dab618e02793f369e7 |
work_keys_str_mv |
AT vandoorenj intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT berghmansn intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT dillenc intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT vanaelsti intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT ronssei intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT israelll intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT rosenbergeri intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT kreuterj intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT lellouchejp intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT michaelis intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT locatellie intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT comesfranchinim intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT aiertzamk intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT saacutenchezabellal intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT loinazi intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT edwardsdr intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT shenkmanl intradermalairpouchleukocytosisasaninvivotestfornanoparticles AT opdenakkerg intradermalairpouchleukocytosisasaninvivotestfornanoparticles |
_version_ |
1718402422814015488 |